Cargando…
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
The abnormal aggregation of amyloid β (Aβ) and its subsequent intra- and extracellular accumulation constitute the disease-causing cascade of Alzheimer’s disease (AD). The detection of Aβ aggregates and senile plaque formation, however, is nearly impossible during early pathogenesis, and the absence...
Autores principales: | Han, Sun-Ho, Chang, Yu Jin, Jung, Eun Sun, Kim, Jong-Won, Na, Duk Lyul, Mook-Jung, Inhee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025587/ https://www.ncbi.nlm.nih.gov/pubmed/21289976 http://dx.doi.org/10.2147/IJN.S15278 |
Ejemplares similares
-
Gold Nanoparticles Mediate Improved Detection of β-amyloid Aggregates by Fluorescence
por: Jara-Guajardo, Pedro, et al.
Publicado: (2020) -
Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
por: Jung, Eun Sun, et al.
Publicado: (2022) -
Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
por: Park, Jong-Chan, et al.
Publicado: (2017) -
Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs
por: Lee, Dongtak, et al.
Publicado: (2021) -
Jowiseungchungtang Inhibits Amyloid-β Aggregation and Amyloid-β-Mediated Pathology in 5XFAD Mice
por: Shin, Soo Jung, et al.
Publicado: (2018)